SEC Form 4 · accession 0001900201-26-000003
MapLight Therapeutics, Inc. · MPLT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Catalyst4, Inc.
10% Owner
Period of report
Jul 28, 2026
Accepted (ET)
Jul 30, 2026 · 6:39 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0001770069
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Voting Common StockF1,F2 | Jul 28, 2026 | P | 141,088 | $10.7416 | A | 19,838,552 | I | See footnote |
| Voting Common StockF3,F2 | Jul 28, 2026 | P | 65,137 | $11.6891 | A | 19,903,689 | I | See footnote |
| Voting Common StockF2 | Jul 29, 2026 | P | 3,000 | $12.63 | A | 19,906,689 | I | See footnote |
| Voting Common StockF2 | Jul 30, 2026 | P | 1,000,000 | $13.00 | A | 20,906,689 | I | See footnote |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.295 to $11.28, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnotes (1) and (3) to this Form 4.
- F2The shares are held of record by Catalyst4, Inc. ("Catalyst4"). As the members of the board of directors of Catalyst4, Robert Brown, Ekemini Riley and Mark Vorsatz share voting and dispositive power with respect to the shares held by Catalyst4. Each of Mr. Brown, Ms. Riley and Mr. Vorsatz disclaims beneficial ownership of the shares reported herein.
- F3The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.31 to $12.00, inclusive.